Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• The human immunodeficiency virus type 1 (HIV-1) envelope, particularly gp120 and gp41, contains critical regions for viral entry and immune evasion.
• Subtype B HIV-1 envelope epitopes are well-characterized, but understanding conserved epitopes across divergent subtypes like E is crucial for vaccine development.

Purpose of the Study:

• To determine if immunogenic epitopes in the HIV-1 subtype B envelope are conserved in structurally analogous regions of the subtype E envelope.
• To identify conserved immunogenic regions within the HIV-1 subtype E envelope despite sequence divergence.

Main Methods:

• Synthesis and analysis of five recombinant peptides from the HIV-1 subtype E envelope, including V2 and V3 domains of gp120, and cysteine-loop, oligomerization, and cytoplasmic tail regions of gp41.
• Serological testing of these peptides against a panel of serum samples to assess reactivity and identify immunogenic epitopes.

Main Results:

• Five recombinant peptides from the HIV-1 subtype E envelope reacted with over 50% of the analyzed serum samples.
• These reactive peptides covered key regions including gp120 V2/V3 domains and gp41 regions (cysteine-loop, oligomerization, cytoplasmic tail).
• The findings indicate a high degree of conservation for immunogenic epitopes between subtype E and B envelopes in structurally analogous regions.

Conclusions:

• Despite significant sequence divergence between HIV-1 subtypes E and B, critical immunogenic epitopes are located in structurally conserved regions of the viral envelope.
• This conservation suggests that therapeutic and prophylactic strategies targeting these epitopes may have broader efficacy across different HIV-1 subtypes.